News

• Wall Street closes mostly higher as tech gains
  09/15/2020 / 22:00 - TeleTrader
•  
• Fortress Biotech Announces Initiation of Phase 3 Studies of CAEL-101 in AL Amyloidosis
  09/14/2020 / 14:00 - GlobeNewswire
•  
• Fortress Biotech to Participate in Three September 2020 Virtual Investor Conferences
  09/10/2020 / 14:00 - GlobeNewswire
•  
• Zealand Pharma builds Global Medical Affairs function with world-renowned experts
  09/04/2020 / 12:00 - GlobeNewswire
•  
• Inozyme Pharma Reports Second Quarter 2020 Financial Results and Provides Business Highlights
  09/03/2020 / 22:05 - GlobeNewswire
•  
• Crinetics Pharmaceuticals Appoints Rare Disease Executive, Camille L. Bedrosian, M.D., to Board of Directors
  09/03/2020 / 13:30 - GlobeNewswire
•  
• Zealand Pharma to participate in upcoming investor conferences
  09/03/2020 / 10:00 - GlobeNewswire
•  
• Ultragenyx Appoints Mardi C. Dier as Chief Financial Officer
  09/02/2020 / 14:01 - GlobeNewswire
•  
• US opens mixed as oil prices increase
  08/31/2020 / 15:30 - TeleTrader
•  
• Clinical Document World Brings Thought Leaders, Innovative Approach to TMF, Inspection Readiness, Document Management, and Clinical Professionals
  08/28/2020 / 15:35 - GlobeNewswire
•  
• Fortress Biotech Announces Positive Topline Clinical Efficacy Results for CUTX-101, Copper Histidinate, for the Treatment of Menkes Disease
  08/28/2020 / 14:30 - GlobeNewswire
•  
• Fortress Biotech Announces $60 Million Loan Agreement with Oaktree Capital Management
  08/28/2020 / 14:00 - GlobeNewswire
•  
• Fortress Biotech Announces Pricing of Series A Preferred Stock Offering
  08/27/2020 / 02:30 - GlobeNewswire
•  
• Zealand Pharma announces acceleration of U.S. commercial operations through the completion of the Valeritas acquisition; FDA acceptance of New Drug Application submission for the dasiglucagon HypoPal® rescue pen; pipeline progress including
  08/13/2020 / 15:00 - GlobeNewswire
•  
• Fortress Biotech Announces Virtual Two-Day Corporate Access Summit Hosted by B. Riley FBR on Tuesday, August 18 and Wednesday, August 19, 2020
  08/12/2020 / 13:30 - GlobeNewswire